These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 17960365)
1. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. McAllister SD; Griffin G; Satin LS; Abood ME J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080 [TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Guo J; Ikeda SR Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245 [TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells. Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849 [TBL] [Abstract][Full Text] [Related]
5. Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. Akinshola BE; Taylor RE; Ogunseitan AB; Onaivi ES Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):242-8. PubMed ID: 10543424 [TBL] [Abstract][Full Text] [Related]
6. Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors. Canals M; Milligan G J Biol Chem; 2008 Apr; 283(17):11424-34. PubMed ID: 18319252 [TBL] [Abstract][Full Text] [Related]
7. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors. Silva GB; Atchison DK; Juncos LI; García NH Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721 [TBL] [Abstract][Full Text] [Related]
8. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103 [TBL] [Abstract][Full Text] [Related]
9. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed. Pakdeechote P; Dunn WR; Ralevic V Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells. Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes. Shivachar AC Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778 [TBL] [Abstract][Full Text] [Related]
14. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. Romano MR; Lograno MD Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084 [TBL] [Abstract][Full Text] [Related]
19. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. Oz M; Yang KH; Dinc M; Shippenberg TS J Pharmacol Exp Ther; 2007 Nov; 323(2):547-54. PubMed ID: 17682128 [TBL] [Abstract][Full Text] [Related]
20. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]